Related party transactions |
6 Months Ended |
|---|---|
Jul. 31, 2026 | |
| Related Party Transactions [Abstract] | |
| Related party transactions | Related party transactions For the three months ended July 31, 2026 and 2025, the Company recognized revenue totaling $380 and $273, respectively, for advertisements placed by a pharmaceutical company. For the six months ended July 31, 2026 and 2025, the Company recognized revenue totaling $699 and $461, respectively, for advertisements placed by the same pharmaceutical company. One of the Company's independent members of its board of directors serves on the board of directors for this pharmaceutical company. As of July 31, 2026 and January 31, 2026, accounts receivable from the pharmaceutical company totaled $380 and $450, respectively.
|